Samumed is a leader in medical research and development for tissue-level regeneration. With our platform's origins in small molecule-based Wnt pathway modulation, we develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
Looking for a particular Samumed, LLC employee's phone or email?
The Samumed, LLC annual revenue was $23.3 million in 2026.
Osman Kibar is the CEO and Founder of Samumed, LLC.
4 people are employed at Samumed, LLC.
Samumed, LLC is based in San Diego, California.
The NAICS codes for Samumed, LLC are [54171, 541714, 5417, 541, 54].
The SIC codes for Samumed, LLC are [873, 87].